All Episodes
Oncology Brothers: Practice-Changing Cancer Discussions — 270 episodes
Challenging Cases in Myelodysplastic Syndrome (MDS) - Dr. Amer Zeidan
Title: Treatment Algorithm of Myelodysplastic Syndrome (MDS) in 2026 - Dr. Thomas LeBlanc
Pancreatic Cancer Management - Partners in Practice with Dr. Tim Brown & Ms. Heather Klein
Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)
Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)
ENDURANCE Trial - Time-limited Lenalidomide Maintenance for Standard Risk Myeloma
Managing Toxicities of CAR-T in Multiple Myeloma (MM) – Drs. Caitlin Costello & Joshua Richter
Challenging Cases in Multiple Myeloma – Drs. Marco Davila & Krina Patel
Treatment Algorithm of Smoldering Myeloma & Newly Diagnosed Multiple Myeloma (NDMM)
EHA2026 Leukemia Highlights: OPTI-AML, KOMET-007, SENTRY
Challenging Cases in Diffuse Large B-cell Lymphoma (DLBCL) - Drs. Gilles Salles & Matt Lunning
EHA2026 Lymphoma Highlights: frontMIND, POLAR-BEAR, HD-MTX for CNS Lymphoma, EPCORE FL-1
Sacituzumab +/- Pembrolizumab FDA Approval in Triple Negative Breast Cancer: ASCENT-03 / ASCENT-04
ASCO 2026 Breast Highlights: OPTIMA, lidERA, VIKTORIA-1, KEYNOTE-522, ASCENT-03/04, TROPION-Breast02
EHA2026 Multiple Myeloma Highlights: CEPHEUS, MajesTEC-3, MajesTEC-9, MonumenTAL-3, SUCCESSOR-2
Evolving Treatment Landscape of Multiple Myeloma: Bispecifics, CAR T, and CELMoDs
Challenging Cases - Treatment of Renal Cell Carcinoma (RCC): Dr. Pedro Barata
ASCO 2026 GU Highlights & FDA Approvals with Drs. Brian Rini & Tom Powles (The Uromigos)
To hold or NOT to hold Systemic Therapy with Radiation: Dr. Nina Sanford
ASCO 2026 GI Highlights: EMERALD-3, FIGHT-302, CIRCULATE, MATTERHORN
RASolute 302 Pancreatic Cancer Study with Daraxonrasib at ASCO 2026 – Dr. Brian Wolpin
ASCO 2026 Head & Neck AND Sarcoma Highlights – Drs. Samantha Armstrong & Ari Rosenberg
Challenging Cases - Treatment of Common EGFR Mutations in Metastatic Non-Small Cell Lung Cancer
Lung Cancer ASCO 2026 Highlights: LIBRETTO-432, CROWN Update, CHRYSALIS-2, HARMONi-6
RASolute-302 with Daraxonrasib - Game Changer at ASCO 2026 in Pancreatic Cancer
ESMO Breast 2026 Highlights - VERITAC-2, PREcoopERA, PHERGain, SATEEN/BRE-354, TROPION-Breast02
Challenging Cases in Relapsed/Refractory Acute Myeloid Leukemia (AML): Dr. Joshua Zeidner
Challenging Cases in Chronic Myeloid Leukemia (CML): Drs. Fadi Haddad & Gaby Hobbs
Managing Toxicities of BRAF-MEK Inhibitors in Non-Small Cell Lung Cancer – Dr. Melissa Johnson
Treating BRAF V600E Mutated Non-Small Cell Lung Cancer (NSCLC) with Dr. Gregory Riely
Managing Toxicities of Bispecific Antibodies in Multiple Myeloma–Drs. Hamza Hashmi & Cesar Rodriguez
Managing Toxicities of EGFR Inhibitors in Lung Cancer – Drs. Azam Farooqui & Joshua Sabari
How to Treat Metastatic NSCLC with Targetable Mutations – Treatment Algorithm with Dr. Eric Singhi
How to Treat Metastatic NSCLC W/O Targeted Mutations – Treatment Algorithm with Dr. Christine Garcia
How to Treat Localized Non-Small Cell Lung cancer – Treatment Algorithm with Dr. Sanjay Popat
How to Treat Small Cell Lung Cancer (SCLC) – Treatment Algorithm with Dr. Jacob Sands
Managing Toxicities of Colorectal Cancer Drugs / Systemic Therapy – Dr. Rona Yaeger
BREAKWATER Study for BRAF V600E Mutated Colorectal Cancer – Encorafenib + Cetuximab + Chemotherapy
How to Treat Colorectal Cancer – Treatment Algorithm with Dr. Smitha Krishnamurthi
How to Treat Pancreatic Cancer – Treatment Algorithm with Dr. Shubham Pant
How to Treat Biliary Tract Cancer – Treatment Algorithm with Dr. Suneel Kamath
How to Treat Cancer of Unknown Primary (CUP) Origin – Drs. Harry Fuentes & Thor Halfdanarson
How to Treat Bladder Cancer – Drs. Stephanie Berg (Medical Oncologist) & Joshua Meeks (Urologist)
Open Evidence as an Artificial Intelligence (AI) Tool in the World of Medicine
How to Treat Renal Cell Carcinoma (RCC) in 2026 – Dr. Katy Beckermann
Evolving Treatment Landscape of HER2+ Upper GI Cancer
How to Treat Prostate Cancer Localized to Advanced Settings - Dr. Scott Tagawa
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer
GU ASCO 2026 Highlights – CREST, POTOMAC, EV-304/KEYNOTE-B15, LITESPARK-011/022, CAPITELLO-281
Clinical Insights: Evolving Landscape of Bladder Cancer After GU ASCO 2026
Teclistamab-Daratumumab FDA Approval of MajesTEC-3 for R/R Multiple Myeloma (MM): Dr. Luciano Costa
Triple Negative Breast Cancer (TNBC) Treatment Algorithm: Dr. Tiffany Traina
Combination Approaches in PD-L1–Positive Metastatic Triple Negative Breast Cancer
HER2+ Breast Cancer Treatment Algorithm: Dr. Virginia Kaklamani
Metastatic Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Kevin Kalinsky
Early Stage Hormone Receptor Positive (HR+) Breast Cancer Treatment Algorithm: Dr. Erica Mayer
Current & Future Role of Anktiva (N-803): Dr. Patrick Soon-Shiong
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv HER2 Breast Cancer: DESTINY-Breast09
Navigating Acute Myeloid Leukemia Treatment: Therapy-Related & De Novo AML with Dr. Naval Daver
Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun
FDA Approval of Daratumumab in High Risk Smoldering Myeloma: AQUILA by Dr. Vincent Rajkumar
ASH 2025 Multiple Myeloma Highlights – AQUILA, COBRA, TecLILLE, MajesTEC-3: Dr. Ben Derman
GI ASCO 2026 Highlights MATTERHORN, HERIZON-GEA-01, BREAKWATER, COMMIT – Dr. Rachna Shroff
ASH 2025 Lymphoma Highlights - EPCORE FL-1, CLL-17, BRUIN CLL-313, SWOG-1826: Dr. Julie Vose
ASH 2025 Leukemia Highlights PARADIGM, KOMET-007, ASC4FIRST, ASC2ESCALATE - Dr. Jorge Cortes
HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein
Triple Negative Breast Cancer SABCS 2025 Highlights: Dr. Rebecca Shatsky
Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles
Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope Rugo
Early HR+ Disease SABCS 2025 Practice Changing/Informing Highlights: ALTTO, lidERA, NATALEE
Advancements and Challenges in Metastatic Colorectal Cancer Treatment
Clinical Implications of Testing HER2 and Targeted Therapies Approved - Dr. Komal Jhaveri
Toxicity Management of HER2+ Treatment Options in Upper GI Cancers – Drs. Geoffrey Ku & Shruti Patel
Current Treatment Landscape of Advanced Gastric/Esophageal/GEJ Adenocarcinoma – Dr. Rutika Mehta
Managing Toxicities of Antibody Drug Conjugates (ADCs) in Lung Cancer – Dr. Jacob Sands
Managing Toxicities of PI3K & AKT Inhibitors in Breast Cancer – Drs. Emily Gallagher & Neil Iyengar
Challenging Cases of Iron Abnormalities, Anemia or Iron Overload - Dr. Marina Beltrami
FDA Approval of Epcoritamab-Rituximab-Lenalidomide for R/R Follicular Lymphoma – Dr. Gilles Salles
Challenging Cases in Second Line & Beyond Renal Cell Carcinoma (RCC) - Dr. David Braun
FDA Approval of Durvalumab with FLOT in Resectable Gastric & GEJ: MATTERHORN by Dr. Yelena Janjigian
Challenging Cases in Breast Cancer with CDK 4/6 Inhibitors – Drs. Sara Tolaney & Adam Brufsky
Challenging Cases in Non-Muscle Invasive Bladder Cancer (NMIBC) – Drs. Shilpa Gupta & Joshua Meeks
FDA Approval of Ziftomenib (KOMET-001) in NPM1 mut Acute Myeloid Leukemia (AML) – Dr. Eunice Wang
Managing Toxicities of ROS1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC) – Dr. Estela Rodriguez
Managing Toxicities of Tyrosine Kinase Inhibitors (TKI) in CML - Drs. Onyee Chan & Fadi Haddad
Lung Cancer ESMO 2025 Highlights: MDT-BRIDGE, FLAURA2, SOHO-01, Beamion LUNG-1
GI Cancer ESMO 2025 Highlights: DYNAMIC-III, PEGASUS, STELLAR-303, MATTERHORN, FORTITUDE-101
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Current Treatment Landscape of Ovarian Cancer with Dr. Sharyn Lewin
GU Cancer ESMO 2025 Highlights: PSMAddition, Capitello-281, Potomac, Keynote-905, IMVigor011
Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
Managing Toxicities of CDK4/6 Inhibitors in Hormone Positive Breast Cancer - Dr. Stephanie Graff
Treating and Managing Chronic Myeloid Leukemia (CML) in 2025: Dr. Jorge Cortes
How to Manage Thrombocytopenia (ITP, HIT, DIC, TTP) - Dr. Ronak Mistry
IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)
Exploring the role of targeted radiopharmaceutical treatment in NETs
Challenging Cases of Venous Thromboembolism (VTE) - Drs. Jennifer Vaughn & Nicolas Gallastegui
How to Treat Cutaneous Melanoma in 2025 - Dr. Omid Hamid
Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
WCLC 2025 Highlights: FLAURA2, HARMONi, ALCHEMIST with Dr. Balazs Halmos
Treating and Managing Chronic Lymphocytic Leukemia (CLL) in 2025: Dr. Mazyar Shadman
Managing Side Effects of New Treatments for Small Cell Lung Cancer
FDA Approval of Zongertinib for HER2 Mutated Non-Small Cell Lung Cancer (NSCLC) - Dr. Joshua Sabari
Latest Clinical Data for First-line Maintenance and R/R Small-Cell Lung Cancer (SCLC)
FDA Approval of Datopotamab deruxtecan (Dato-DXd) in EGFR Mutated Lung Cancer - Dr. Jacob Sands
Diagnosis and Treatment of Myelofibrosis with Dr. Raajit Rampal: Testing, Treatment, Supportive care
Managing Toxicities of TKIs and HIF-2 inhibitor in Renal Cell Carcinoma (RCC)
Myeloproliferative Neoplasms (MPN) Treatment: Polycythema Vera (PV) & Essential Thrombocythemia (ET)
Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer
Challenging Cases with Relapsed/Refractory FLT3+ Acute Myeloid Leukemia (AML)
Treating Acute Myeloid Leukemia in 2025 - Induction, Consolidation, Transplant, Target Therapies
Challenging Cases with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA
FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial
ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04
ASCO 2025 - GI Cancer Highlights: DYNAMIC III, ATOMIC, BREAKWATER, MATTERHORN, DESTINY Gastric04
ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304
Nivolumab plus Ipilimumab in Microsatellite-Instability–High (MSI-H) Metastatic Colorectal Cancer
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
How to treat Small Cell Lung Cancer in 2025
Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
Treatment Options for HER2 Positive Biliary Tract Cancers
The HER2 Diagnostic and Treatment Landscape in NSCLC
Overview of Biliary Tract Cancer & Importance of Targeted Therapies
What does it mean to be HER2 Positive in Lung Cancer
European Lung Cancer Conference (ELCC) 2025 Highlights: KEYNOTE-799, LAURA, MARIPOSA, KRYSTAL-7
FDA Approval of Cabozantinib - CABINET in pNET and epNET
How to Manage & Treat Pancreatic Cancer
How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment
Prostate Cancer Management from Early Stage to Advanced Metastatic Disease - Dr. Alan Bryce
How to Treat Renal Cell Carcinoma (RCC) using a Treatment Algorithm with Dr. Katy Beckermann
How to Treat Bladder Cancer in 2025 with Dr. Joaquim Bellmunt
FDA Approval of Tislelizumab - RATIONALE 305 and 306 in Upper GI Cancers
GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2
How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025
FDA Approval of Zolbetuximab SPOTLIGHT / GLOW study - Upper GI Cancer with Claudin 18.2 Mutation
How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons
How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET
FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo
Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka
SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies
SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy
CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
2nd line treatment in advanced HCC and when to switch
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
How to Approach and Treat Pancreatic Cancer
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
Palliative Care Management in Cancer
How to Approach to Ovarian Cancer from Community Oncology Perspective
How to Approach to Endometrial Cancer from Community Oncology Perspective
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
Role of Cardiology in Cancer Treatment: Cardio-Oncology
How to Treat Early Stage Non-Small Cell Lung Cancer
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
Multidisciplinary Approach for Rectal Cancer - Discussion with Dr. Deb Schrag & Dr. Krishan Jethwa
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju
Understanding Disparities in Colorectal Cancer Care
Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi
Liver Directed Therapies - Interventional Radiology & Radiation Oncologist Perspective
Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello
Discussion on Evolving CLL Treatment Strategies with Dr. Nitin Jain
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Standard of Care Treatment for Upper GI Cancer: A Discussion with Dr. Sam klempner
Standard of Care Treatment for Colon Cancer: A Discussion with Dr. Aparna Parikh
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles
Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
How to treat Prostate Cancer in 2024 with Dr. Rana McKay
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers
GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564
How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein
GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2
How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss
ASH 2023 Leukemia/MDS/Myelofibrosis Highlights – TRANSFORM-1, MANIFEST-2, SAVE, AUGMENT-101 with Dr. Uma Borate
SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02
SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01
ASH 2023 CLL/Lymphoma Highlights – ALPINE, SEQUOIA, SWOG-S1826, POLARIX Update with Dr. Mazyar Shadman
ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3 Update with Dr. Jens Hillengass
SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update
How to Treat Myelodysplastic Syndrome (MDS) with Dr. Amer Zeidan
ESMO 2023 GI Cancer Highlights – Codebreak300, CABINET, GASTFOX
ESMO 2023 Lung Cancer - Chapter 2 Highlights – PAPILLON, MARIPOSA, MARIPOSA-2, LIBRETTO-431
ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc Brothers
ESMO 2023 GU Cancer Highlights – SunRISE-1, EV-302, PSMAfore
ESMO 2023 Lung Cancer Highlights – Keynote 671 | ALINA | TropionLung01 | Oncology Brothers
How to Treat Cutaneous Melanoma - Deep Dive with Dr. Sapna Patel
2023 World Conference on Lung Cancer Highlights | Dr. Stephen Liu | Oncology Brothers #2023
How to Treat Chronic Lymphocytic Leukemia (CLL) with Dr. Jeff Sharman
Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin's Lymphoma
Story of Hope by a Determined Lung Cancer Survivor - Jill Feldman
EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab
How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar
How to Treat Multiple Myeloma with Dr. Jens Hillengass
Critical Updates in Kidney, Prostate, and Bladder Cancer from ASCO 2023 with Dr. Toni Choueiri
GI Cancer ASCO 2023 Highlights with Dr. Muhammad Shaalan Beg
Lung Cancer ASCO 2023 Highlights with Dr. Charu Aggarwal
Breast Cancer ASCO 2023 Highlights with Dr. Stephanie Graff
EMERALD Ph III Study in discussion w/ Dr. Virginia Kaklamani (now FDA Approved)
Colon Cancer Algorithm Discussion with Dr. Cathy Eng
American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology
HR+ Breast Cancer Management with Dr. Margaret Gatti-Mays
HR+ Invasive Lobular Carcinoma Management with Dr. Jason Mouabbi
HER2+ Breast Cancer Algorithm Discussion with Dr. Paolo Tarantino
Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations - Dr. Jarushka Naidoo
Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/o Targetable Mutations - Dr. Eric Singhi
Localized Non-Small Cell Lung Cancer (NSCLC) Algorithm with Dr. Charu Aggarwal
Small Cell Lung Cancer (SCLC) Algorithm with Dr. Estelamari Rodriguez
MOUNTAINEER Study in discussion w/ Dr. Bekaii-Saab (Tucatinib and Trastuzumab FDA Approval for advanced colorectal cancer)
GU ASCO 2023 Highlights with Dr. Petros Grivas
Prostate Cancer Algorithm with Dr. Neeraj Agarwal
EMERALD Ph III Study in discussion w/ Dr. Aditya Bardia (now FDA Approved)
GI ASCO 2023 Highlights with Dr. Mark Lewis
The NICHE-2 Study Discussion with Dr. Myriam Chalabi
Bladder Cell Cancer Algorithm Discussion with Dr. Andrea Apolo
Kidney / Renal Cell Cancer Algorithm Discussion with Dr. Elizabeth Plimack
DESTINY-Breast04 Study Discussion with Dr. Shanu Modi
TNBC SABCS 2022 Highlights with Dr. Maryam Lustberg
ASH 2022 Highlights with Dr. Aaron Goodman "Papa Heme"
HER2+ SABCS 2022 Highlights with Dr. Erika Hamilton
HR+ SABCS 2022 Highlights with Dr. Stephanie Graff
CDK4/6i in HR+ SABCS 2022 Highlights with Dr. Sara Tolaney
Upper Gastrointestinal (GI) Cancer Algorithm with Dr. Rutika Mehta
Triple Negative Breast Cancer (TNBC) Algorithm with Dr. Shipra Gandhi
HER2-positive Breast Cancer Algorithm with Dr. Erika Hamilton
Hormone Positive Breast Cancer Algorithm with Dr. Stephanie Graff
Melanoma ESMO 2022 Highlights with Dr. Sapna Patel
Lung Cancer ESMO 2022 Highlights with Dr. Joshua Reuss
Breast Cancer ESMO 2022 Highlights with Dr. Maryam Lustberg
GI Cancer ESMO 2022 Highlights with Dr. Rachna Shroff
Genitourinary Cancer ESMO 2022 Highlights with Dr. Toni Choueiri
Introduction: @OncBrothers - Drs. Rohit and Rahul Gosain, and their mission